您好,欢迎来到皮书数据库!
热点推荐: 双循环
更多>> 课题组动态
更多>> 皮书作者
谢伏瞻
    中国社会科学院学部委员,学部主席团主席,研究员,博士生导师。历任中国社会科学院院长、党组书记,国务院发展中心副主... 详情>>
蔡 昉
    中国社会科学院国家高端智库首席专家,学部委员,学部主席团秘书长,研究员,博士生导师。先后毕业于中国人民大学、中国... 详情>>
李培林
    男,汉族,出生于1955年5月,山东济南人,博士,研究员,全国人民代表大会社会建设委员会副主任委员,中国社会科学... 详情>>

    2016~2021年中国中医药科研能力评价报告

    摘要

    本报告从科研经费、科研人员、科研课题、科研论文和专利方面选取5个三级指标进一步完善中医药科研能力评价指标体系,采用德尔菲法进行专家咨询确定各级指标的权重,计算31个省(区、市)中医药科研能力得分,并对2019年和2018年的得分进行纵向比较,深入分析中医药科研能力的区域差异和受政策影响的年度变化趋势。笔者发现2019年与2018年相比中医药科研能力评价各项指标得分略有浮动,北京市、重庆市以人口少、中医药科研机构集中的优势连续两年排名靠前,中西部地区中医药科研创新发展较快。“中医药强省”战略规划对省际中医药科研能力竞争力也有显著积极的影响。本报告认为,亟待建立一套更加科学、合理、可行的中医药科研创新绩效评价指标体系,以鼓励各省(区、市)出台中医药科研创新激励导向政策,充分发挥本地中医药道地资源优势。

    <<
    >>

    Abstract

    This report selects five three-level indicators from the aspects of scientific research funding,scientific research personnel,scientific research grants,scientific research papers and patents to further improve the evaluation indicators of Chinese medicine scientific research and innovation capabilities. The Delphi method was used for expert consultation to determine the weights of all levels of indicators. The indicators were calculated among 31 provinces (autonomous regions and municipalities) between 2019 and 2018. Regional differences and annual change affected by policies were analyzed. It was found that the scores of various indicators in the evaluation of Chinese medicine scientific research and innovation ability in 2019 and 2018 fluctuated slightly. Beijing and Chongqing have been ranked high for two consecutive years with their small population and concentrated traditional Chinese medicine research institutions. However,the level of scientific research and innovation of traditional Chinese medicine in the central and western regions has developed rapidly. The strategic plan of “Strengthening the Province of Traditional Chinese Medicine” also has a significant positive impact on the competitiveness of inter-provincial research and innovation of Chinese medicine. This report believes that it is urgent to establish a scientific,reasonable and feasible performance evaluation index system for scientific research and innovation of traditional Chinese medicine,and all provinces (autonomous regions and municipalities) should issue incentive policies for scientific research and innovation of traditional Chinese medicine and make full use of the advantages of local traditional Chinese medicine resources.

    <<
    >>
    作者简介
    邹冠炀:邹冠炀,广州中医药大学公共卫生与管理学院杏林学者,副教授,硕士生导师,研究方向为卫生事业管理和医院管理。
    高婧:高婧,广州中医药大学公共卫生与管理学院在读博士研究生,广州中医药大学护理学院讲师,研究方向为中医药管理、老年护理。
    <<
    >>
    相关报告